NCT05775874 2023-03-20A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUCAbbisko Therapeutics Co, LtdPhase 2 Unknown80 enrolled
NCT04730219 2022-11-30Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder CarcinomaTianjin Medical University Second HospitalPhase 2 Unknown48 enrolled